Waldencast (NASDAQ:WALD) Price Target Cut to $8.00

Waldencast (NASDAQ:WALD) had its price objective lowered by Telsey Advisory Group from $10.00 to $8.00 in a research report sent to investors on Wednesday, MarketBeat Ratings reports. Telsey Advisory Group currently has an outperform rating on the stock.

Waldencast Stock Performance

Shares of WALD opened at $5.06 on Wednesday. The stock’s 50-day moving average price is $6.32 and its 200 day moving average price is $8.11. Waldencast has a 12-month low of $4.71 and a 12-month high of $12.00.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Amalgamated Bank boosted its stake in Waldencast by 68.1% during the third quarter. Amalgamated Bank now owns 3,277 shares of the company’s stock worth $31,000 after buying an additional 1,328 shares in the last quarter. Barclays PLC lifted its holdings in shares of Waldencast by 75.3% during the 3rd quarter. Barclays PLC now owns 7,177 shares of the company’s stock worth $67,000 after acquiring an additional 3,084 shares during the period. SG Americas Securities LLC boosted its position in shares of Waldencast by 23.2% during the 4th quarter. SG Americas Securities LLC now owns 19,705 shares of the company’s stock valued at $216,000 after acquiring an additional 3,716 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Waldencast by 44.4% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,226 shares of the company’s stock valued at $178,000 after acquiring an additional 4,992 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System bought a new stake in Waldencast in the third quarter valued at about $97,000. 41.97% of the stock is currently owned by institutional investors and hedge funds.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.